ACUR
ACURA PHARMS INC
stock OTC

acura pharmaceuticals, inc. is a specialty pharmaceutical company engaged in the research, development and commercialization of technologies and products intended to address medication abuse and misuse. we have discovered and developed three proprietary technology platforms to address abuse and misuse across multiple fronts. • limitx™ technology is designed to retard the release of active drug ingredients when an excess number of tablets are ingested. in 2014, we were awarded a $300,000 grant from the national institute on drug abuse to advance early stage development of our limitx technology. • aversion® technology is a patented composition of commonly used active and inactive pharmaceutical ingredients providing abuse deterrent features to discourage common methods of pharmaceutical product misuse and abuse while providing effective pain relief. oxaydo® tablets (oxycodone hcl, cii), is the first approved product using aversion® in the united states. on january 7, 2015, we entered int